'Critical step': Go for Recce's Phase III trials after banking $15.8M in capital raise, page-10

confirmation bias = formal ASX released on trial timelines and partners vs plucking opinion from my rear?
whatever source he can = the company making said formal release and being discussed?
insults and name calling = addressing BelowAverage as Below Average?
irrelevant countries = the fourth most populous country in the world with a higher proliferation of diabetes and DFU and some 20 million+ sufferers?
falling pianos = +10% in 1 month?

Your perception on reality a little off the mark on every front.

This all ultimately all about you really not understanding bio-tech investment timelines of course - and obviously getting burnt on poor past investment decisions and blaming anything but your own judgement. Your expectations would otherwise not be surprised at RCE being a phase III company still yet to achieve commercial revenues, a decade after listing. Not at all unusual alas. But, RCE management, presuming they tardy as ever, possibly on the verge of commercial revenues in 2H CY26 on my expectation (vs their 1H guidance - there is that confirmation bias again).

Keep up the acrimony Rykster. Making your really desperate attempts at personal insult (ergo you) look silly, is always a pleasure.